{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T10:40:19Z","timestamp":1782297619520,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s10067-013-2333-0","type":"journal-article","created":{"date-parts":[[2013,7,15]],"date-time":"2013-07-15T12:07:49Z","timestamp":1373890069000},"page":"1633-1640","source":"Crossref","is-referenced-by-count":17,"title":["Questionnaire survey evaluating disease-related knowledge for 149 primary gout patients and 184 doctors in South China"],"prefix":"10.1007","volume":"32","author":[{"given":"Qian-Hua","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lie","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Juan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Ou-Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Qian","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Ralph","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,16]]},"reference":[{"key":"2333_CR1","first-page":"2041","volume":"33","author":"W Fang","year":"2006","unstructured":"Fang W, Zeng X, Li M, Chen LX, Schumacher HJ, Zhang F (2006) The management of gout at an academic healthcare center in Beijing: a physician survey. J Rheumatol 33:2041\u20132049","journal-title":"J Rheumatol"},{"key":"2333_CR2","first-page":"860","volume":"31","author":"JW Yu","year":"2010","unstructured":"Yu JW, Yang TG, Diao WX, Cai XQ, Li T, Zhong H et al (2010) Epidemiological study on hyperuricemia and gout in Foshan areas, Guangdong Province. Zhonghua Liu Xing Bing Xue Za Zhi 31:860\u2013862","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"2333_CR3","first-page":"66","volume":"116","author":"Q Zeng","year":"2003","unstructured":"Zeng Q, Wang Q, Chen R, Xiao Z, Huang S, Xu J (2003) Primary gout in Shantou: a clinical and epidemiological study. Chin Med J (Engl) 116:66\u201369","journal-title":"Chin Med J (Engl)"},{"key":"2333_CR4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237\u2013241","journal-title":"Nature"},{"key":"2333_CR5","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P et al (2006) EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1312\u20131324","journal-title":"Ann Rheum Dis"},{"key":"2333_CR6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/ard.2006.055251","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Pascual E, Bardin T, Barskova V, Conaghan P et al (2006) EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1301\u20131311","journal-title":"Ann Rheum Dis"},{"key":"2333_CR7","first-page":"410","volume":"15","author":"Chinese Rheumatology Association","year":"2011","unstructured":"Chinese Rheumatology Association (2011) The diagnosis and treatment guideline of primary gout. Chin J Rheumatol 15:410\u2013413","journal-title":"Chin J Rheumatol"},{"key":"2333_CR8","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1136\/annrheumdis-2012-201687","volume":"71","author":"M Doherty","year":"2012","unstructured":"Doherty M, Jansen TL, Nuki G, Pascual E, Perez-Ruiz F, Punzi L et al (2012) Gout: why is this curable disease so seldom cured? Ann Rheum Dis 71:1765\u20131770","journal-title":"Ann Rheum Dis"},{"key":"2333_CR9","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1185\/03007995.2010.533647","volume":"26","author":"RA Brook","year":"2010","unstructured":"Brook RA, Forsythe A, Smeeding JE, Lawrence EN (2010) Chronic gout: epidemiology, disease progression, treatment and disease burden. Curr Med Res Opin 26:2813\u20132821","journal-title":"Curr Med Res Opin"},{"key":"2333_CR10","first-page":"114","volume":"25","author":"TR Mikuls","year":"2007","unstructured":"Mikuls TR (2007) Quality of care in gout: from measurement to improvement. Clin Exp Rheumatol 25:114\u2013119","journal-title":"Clin Exp Rheumatol"},{"key":"2333_CR11","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3899\/jrheum.071229","volume":"36","author":"MA Becker","year":"2009","unstructured":"Becker MA, Schumacher HR, Benjamin KL, Gorevic P, Greenwald M, Fessel J et al (2009) Quality of life and disability in patients with treatment-failure gout. J Rheumatol 36:1041\u20131048","journal-title":"J Rheumatol"},{"key":"2333_CR12","first-page":"620","volume":"26","author":"WJ Taylor","year":"2008","unstructured":"Taylor WJ, Colvine K, Gregory K, Collis J, McQueen FM, Dalbeth N (2008) The Health Assessment Questionnaire Disability Index is a valid measure of physical function in gout. Clin Exp Rheumatol 26:620\u2013626","journal-title":"Clin Exp Rheumatol"},{"key":"2333_CR13","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/annrheumdis-2012-201676","volume":"72","author":"F Rees","year":"2013","unstructured":"Rees F, Jenkins W, Doherty M (2013) Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study. Ann Rheum Dis 72:826\u2013830","journal-title":"Ann Rheum Dis"},{"key":"2333_CR14","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T et al (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 64:1431\u20131446","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2333_CR15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/RHU.0b013e318228b4e2","volume":"17","author":"LY Zhang","year":"2011","unstructured":"Zhang LY, Schumacher HR, Su HH, Dai L, Dinnella J, Baker JF et al (2011) Development and evaluation of a survey of gout patients concerning their knowledge about gout. J Clin Rheumatol 17:242\u2013248","journal-title":"J Clin Rheumatol"},{"key":"2333_CR16","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.1780200320","volume":"20","author":"SL Wallace","year":"1977","unstructured":"Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20:895\u2013900","journal-title":"Arthritis Rheum"},{"key":"2333_CR17","first-page":"S1","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation (2002) K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1\u2013S266","journal-title":"Am J Kidney Dis"},{"key":"2333_CR18","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1681\/ASN.2006040368","volume":"17","author":"YC Ma","year":"2006","unstructured":"Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y et al (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17:2937\u20132944","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"2333_CR19","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/annrheumdis-2011-200801","volume":"71","author":"K Spencer","year":"2012","unstructured":"Spencer K, Carr A, Doherty M (2012) Patient and provider barriers to effective management of gout in general practice: a qualitative study. Ann Rheum Dis 71(9):1490\u20131495","journal-title":"Ann Rheum Dis"},{"key":"2333_CR20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/RHU.0b013e31824e1f6f","volume":"18","author":"N Martini","year":"2012","unstructured":"Martini N, Bryant L, Te KL, Aho L, Chan R, Miao J et al (2012) Living with gout in New Zealand: an exploratory study into people's knowledge about the disease and its treatment. J Clin Rheumatol 18:125\u2013129","journal-title":"J Clin Rheumatol"},{"key":"2333_CR21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-4615-5381-6_3","volume":"431","author":"H Yamanaka","year":"1998","unstructured":"Yamanaka H, Togashi R, Hakoda M, Terai C, Kashiwazaki S, Dan T et al (1998) Optimal range of serum urate concentrations to minimize risk of gouty attacks during anti-hyperuricemic treatment. Adv Exp Med Biol 431:13\u201318","journal-title":"Adv Exp Med Biol"},{"key":"2333_CR22","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/ard.2006.060368","volume":"66","author":"E Pascual","year":"2007","unstructured":"Pascual E, Sivera F (2007) Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout. Ann Rheum Dis 66:1056\u20131058","journal-title":"Ann Rheum Dis"},{"key":"2333_CR23","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/art.10511","volume":"47","author":"F Perez-Ruiz","year":"2002","unstructured":"Perez-Ruiz F, Calabozo M, Pijoan JI, Herrero-Beites AM, Ruibal A (2002) Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum 47:356\u2013360","journal-title":"Arthritis Rheum"},{"key":"2333_CR24","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","volume":"353","author":"MA Becker","year":"2005","unstructured":"Becker MA, Schumacher HJ, Wortmann RL, MacDonald PA, Eustace D, Palo WA et al (2005) Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 353:2450\u20132461","journal-title":"N Engl J Med"},{"key":"2333_CR25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11926-010-0154-6","volume":"13","author":"NL Edwards","year":"2011","unstructured":"Edwards NL (2011) Quality of care in patients with gout: why is management suboptimal and what can be done about it? Curr Rheumatol Rep 13:154\u2013159","journal-title":"Curr Rheumatol Rep"},{"key":"2333_CR26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1742395310378761","volume":"6","author":"LR Harrold","year":"2010","unstructured":"Harrold LR, Mazor KM, Velten S, Ockene IS, Yood RA (2010) Patients and providers view gout differently: a qualitative study. Chronic Illn 6:263\u2013271","journal-title":"Chronic Illn"},{"key":"2333_CR27","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/art.22767","volume":"57","author":"JA Singh","year":"2007","unstructured":"Singh JA, Hodges JS, Toscano JP, Asch SM (2007) Quality of care for gout in the US needs improvement. Arthritis Rheum 57:822\u2013829","journal-title":"Arthritis Rheum"},{"key":"2333_CR28","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1097\/RHU.0b013e3181896b1e","volume":"14","author":"AL Weaver","year":"2008","unstructured":"Weaver AL, Cheh MA, Kennison RH (2008) How PCP education can impact gout management: the gout essentials. J Clin Rheumatol 14:S42\u2013S46","journal-title":"J Clin Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2333-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-013-2333-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2333-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:57:27Z","timestamp":1559105847000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-013-2333-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,16]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["2333"],"URL":"https:\/\/doi.org\/10.1007\/s10067-013-2333-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,16]]}}}